Applied Genetic Technologies (AGTC) Files $70M IPO

January 14, 2014 - BioWorld Today

Applied Genetic Technologies, of Alachua, Fla., filed for a $70 million initial public offering, with plans to list on Nasdaq under the symbol “AGTC.” Pricing terms were not disclosed. Barclays and BMO Capital Markets are the joint bookrunners. The company develops treatments for orphan eye diseases.